Key takeaways:
Gabapentin (Neurontin) is FDA-approved to treat specific types of nerve pain and seizures. It’s also sometimes used to treat other health conditions. These include restless leg syndrome, anxiety, and alcohol withdrawal.
Gabapentin isn’t a controlled substance according to the federal government. But several states have passed their own laws classifying gabapentin a schedule V (schedule 5) controlled substance.
Combining gabapentin and opioids can be extremely dangerous. Talk to your healthcare provider about the risks of gabapentin before taking it.
In 2019, U.S. pharmacies dispensed 69 million prescriptions for gabapentin (Neurontin, Gralise). Gabapentin is a medication that’s used in many medical health conditions. These include nerve pain and seizures. In 2021, it was one of the most commonly used medications in the U.S.
Gabapentin was originally FDA-approved in 1993. At that time, it wasn’t known to cause addiction or dependence. But several studies have shown that gabapentin might be riskier than originally thought. It’s estimated that around 1% of people in the U.S. misuse gabapentin.
With rising rates of misuse and addiction, several states have made gabapentin a controlled substance. A controlled substance is a substance with a higher likelihood for addiction and dependence. Here, we’ll talk about the risks associated with gabapentin and why some states consider it a controlled substance.
Gabapentin is FDA-approved to treat a certain type of nerve pain (postherpetic neuralgia). It’s also approved to treat certain types of seizure disorders.
And gabapentin is used to treat other conditions it’s not FDA-approved for (off-label uses) as well.
These include:
Postoperative pain (pain after surgery)
Nerve pain caused by diabetes
We don’t fully understand how gabapentin works for all these health conditions. But it has a similar structure to a chemical in the brain called gamma-aminobutyric acid (GABA). GABA causes drowsiness and relaxation.
Gabapentin isn’t considered a controlled substance by the federal government as of July 2022. But several states consider gabapentin a schedule V (schedule 5) controlled substance. In states where gabapentin is a controlled substance, there’s stricter laws regarding prescribing and dispensing it from pharmacies.
There are five groups of controlled substances. Schedule V substances are the least likely of the controlled substances to cause addiction or dependence. But they’re more likely than non-controlled substances to cause these problems.
Some states have even included gabapentin in their prescription drug monitoring programs (PDMPs). A PDMP is an online database that tracks refills of controlled substance medications. For example, it allows prescribers and pharmacists to see if someone refills a controlled substance at more than one pharmacy. This helps providers and pharmacists notice who may be taking too much of a certain medication and who may be at risk of overdose.
As of July 2022, these states consider gabapentin a schedule V controlled substance:
Alabama
Kentucky
Michigan
North Dakota
Tennessee
Virginia
West Virginia
Other states have mandated gabapentin reporting. Every time you fill a gabapentin prescription, it’s added to the PDMP system. These include:
Connecticut
Kansas
Massachusetts
Indiana
Washington D.C.
New Jersey
Minnesota
Nebraska
Ohio
Utah
Wyoming
Oregon
Some states believe that gabapentin use has significant risks. Gabapentin can cause euphoria (an extremely good feeling) or a “high.” It can also cause you to feel very relaxed. This is especially true with higher doses.
As mentioned above, gabapentin is classified as a schedule V medication in states where it’s a controlled substance. This means the risk of addiction is low compared to other controlled substances. But it’s higher compared to non-controlled substances.
You can limit the side effects and risks of taking gabapentin by:
Taking the lowest dose possible
Following the directions given by your healthcare provider
Avoiding alcohol or other central nervous system (CNS) depressants, like benzodiazepines
Avoiding gabapentin if you have a history of substance use disorder
It’s also important to avoid combining gabapentin and opioids. Studies have found that this combination can be dangerous. Opioids are controlled substances used to treat pain. They’re powerful medications that can cause dependence and addiction.
An opioid overdose is more likely if gabapentin and opioids are used together. According to the CDC, gabapentin was detected in almost 10% of overdose cases from 2019 to 2020.
We’re not sure exactly why this occurs. It may be that combining gabapentin and opioids can raise the risk of breathing problems. It may also be that the presence of opioids raises gabapentin levels to a dangerous amount in the body.
Gabapentin isn’t considered a controlled substance by the federal government. But several states have passed their own laws limiting the prescribing and sale of it. Eight states have made gabapentin a schedule V controlled substance. And 12 other states require stricter reporting on gabapentin prescriptions.
If you have a prescription for gabapentin, it’s best to take the lowest dose possible. And you should only take it as prescribed by your healthcare provider. Avoid combining gabapentin with opioids, alcohol, or other medications that affect the central nervous system (like benzodiazepines).
If you or someone you know struggles with substance use, help is available. Call SAMHSA’s National Helpline at 1-800-662-HELP (4357) to learn about resources in your area.
Ahmed, S., et al. (2019). Use of gabapentin in the treatment of substance use and psychiatric disorders: A systematic review. Frontiers in Psychiatry.
Centers for Disease Control and Prevention. (2021). Prescription drug monitoring programs (PDMPs).
Collins, S. (2021). More states make gabapentin a Schedule V controlled substance. Pharmacy Today.
Gomes, T., et al. (2017). Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study. PLOS Medicine.
Jewett, B., et al. (2021). Physiology, GABA. StatPearls.
Lennox, R., et al. (2019). Gabapentin misuse. Canadian Medical Association Journal.
Mattson, C., et al. (2022). Notes from the field: Trends in gabapentin detection and involvement in drug overdose deaths – 23 states and the District of Columbia, 2019-2020. Morbidity and Mortality Weekly Report.
Merfelder, T., et al. (2015). Gabapentin: Abuse, dependence, and withdrawal. Annals of Pharmacotherapy.
National Institute on Drug Abuse. (2018). Prescription CNS depressants DrugFacts.
Oregon Health Authority. (n.d.). Prescription Drug Monitoring Program.
Peckham, A., et al. (2018). Gabapentin for off-label use: Evidence-based or cause for concern? Substance Abuse.
RPK Pharmaceuticals. (2022). Gabapentin [package insert].
Substance Abuse and Mental Health Services Administration. (2022). SAMHSA’s national helpline.
Shaw, G. (2022). Should gabapentin be a controlled substance? American Academy of Neurology.
Smith, B., et al. (2012). Substance misuse of gabapentin. British Journal of General Practice.
Smith, R., et al. (2015). Abuse and diversion of gabapentin among nonmedical prescription opioid users in Appalachian Kentucky. American Journal of Psychiatry.
Smith, R., et al. (2016). Gabapentin misuse, abuse, and diversion: A systematic review. Addiction.
U.S. Department of Justice Drug Enforcement Administration. (n.d.). Controlled substance schedules.
U.S. Food and Drug Administration. (2020). FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR).
Yasaei, R., et al. (2022). Gabapentin. StatPearls.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.